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Background: The purpose of the current study is to evaluate the surgical outcome for rhegmatogenous retinal
detachment (RD) associated with Behçet’s disease (BD).
Methods: The current retrospective study included all patients operated for rhegmatogenous RD associated with
BD in our institution from June 2007 to June 2012. Surgical repair was done either by scleral buckling (SB) or pars
plana vitrectomy (PPV) according to the topography and clinical criteria of the detachment.
Results: The current study included 7 eyes of 7 patients (6 males and one female). The mean age was 34.3 ±
4.9 years and all patients showed systemic features of BD. In 3 eyes, intravitreal triamcinolone acetonide (IVTA) was
injected within 8 weeks prior to the occurrence of rhegmatogenous RD. Five eyes were treated with SB (segmental
buckle in 4 cases and encircling buckle in one case) and 2 cases were treated by PPV. One case was initially treated
by SB but showed recurrence of RD which was surgically repaired by PPV with successful closure of the retinal
break. The retina was successfully reattached in all cases at the end of follow up period (22.0 ± 6.7 months).
Conclusions: Rhegmatogenous RD in BD can be effectively treated by scleral buckling in selected cases and PPV in
more complex cases. Intravitreal injections may be a precipitating factor for rhegmatogenous RD.
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Scleral bucklingBackground
Behçet's disease (BD) is multisystem disease character-
ized by recurrent attacks of vasculitis involving small,
medium and large blood vessels of unknown cause [1].
The hallmark of BD is the recurrent episode of painful
ulcers in the mouth and genitalia. BD often affects other
systems in the body leading to skin lesions, arthritis and
less frequently neurological, gastrointestinal and cardio-
vascular manifestations. BD is seen more commonly
around the Mediterranean region, including Egypt, and
the Far East [1,2].
Ocular involvement of BD is usually bilateral and typic-
ally presents during the working age group between the
second and fourth decade. Ocular complications may occur
in up to 95% of males and 70% of females with dramatic* Correspondence: daboursh490@yahoo.com
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article, unless otherwise stated.impact on vision. They include relapsing remitting panuvei-
tis, retinal obliterative and necrotizing vasculitis, vitritis, vit-
reous hemorrhage, serous macular detachment, and rarely
rhegmatogenous retinal detachment [2-6].
Pars plana vitrectomy has been reported to treat several
posterior segment complications in patients with BD in-
cluding vitreous hemorrhage, vitreous opacities, macular
hole, and epiretinal membrane [7-12]. However there is
only limited data on the surgical management of rhegma-
togenous retinal detachment in eyes with BD [13,14].
In the study herein, we described a series of seven eyes
with BD presented with rhegmatogenous RD with focus
on the clinical course and visual outcome with surgical
intervention.Methods
We retrospectively reviewed the medical records of patients
who underwent surgical intervention for rhegmatogenousntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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from June 2007 to June 2012. The Zagazig University Insti-
tutional Review Board (ZUIRB) approved this study, which
adhered to the tenets of the Declaration of Helsinki.
Behçet’s disease was diagnosed according to the cri-
teria of the international study group for Behçet’s disease
(ISG) [15]. BD was considered if the subject has recur-
rent oral ulceration in addition to two of the following
features; eye lesions, genital ulcers, skin lesions and posi-
tive pathergy test. All patients were on oral immuno-
modulatory therapy (Methotrexate or Cyclosporine or
Azathioprine) with or without oral corticosteroids.
All subjects underwent a comprehensive ocular examin-
ation, including best-corrected visual acuity (VA) meas-
urement (and corresponding log MAR conversion values),
slit lamp examination, intraocular pressure measurement,
and dilated color fundus photography (TRC50DX; Top-
con Corp., Tokyo, Japan). Ultrasonographic evaluation
(Sonomed, EZ scan AB5500+, New York, USA) was per-
formed in all eyes just before surgical intervention.
Topical steroid eye drops (prednisolone acetate 1%) and
systemic steroid (prednisolone 1 mg/Kg/day) were used
for all patients prior to surgery. Eyes with single breaks
with relatively healthy vitreous in the absence of any trac-
tion were treated by segmental scleral buckling procedure.
Scleral buckling was combined with cryotherapy applica-
tion and drainage of subretinal fluid. PPV was performed
in eyes with more than one break or eyes with dense vitre-
ous opacities or eyes that developed PVR.
All surgical interventions were done under general
anesthesia. Conventional 3 port pars plana vitrectomy
(PPV) procedure using 20-gauge vitrectomy system coupled
with non-contact wide field viewing system (BIOM,
OCULUS Optikgeräte GmbH, Wetzlar, Germany) with
additional chandelier light when needed. During the
surgery, the aim was to remove all vitreous as much as
possible, all epiretinal membranes, and complete shaving
of the vitreous base. In eyes operated with PPV, silicon
oil tamponade was used at the end of the procedure. In
all eyes, triamcinolone acetonide 40 mg (Kenacort-A,
Bristol-Myers Squibb, 40 mg/1 ml) was injected into
the subtenon space at the end of the surgery. All pa-
tients were hospitalized for 3–5 days postoperatively
according to the course of the disease. The systemic
corticosteroid therapy was tapered postoperatively ac-
cording to the severity of the inflammation.
Results
In the current study, seven eyes of 7 patients (6 (85.7%)
males and (14.3%) female) with rhegamtougenous RD
associated with BD were included. The mean age was
34.3 ± 4.9 years (range from 28 to 42 years). The mean
time elapsed since diagnosis of BD was 5.4 ± 1.6 years
(range from 3 to 7 years).Characteristics of the patients are summarized in
Table 1. All patients experienced other symptoms of BD
including oral ulcers (all patients), genital ulcers (5 sub-
jects) and skin lesions (3 subjects) and arthritis (3 sub-
jects). All patients experienced recurrent attacks of
anterior uveitis with remissions and exacerbations and
all had a history of posterior uveitis. There is no pre-
operative cataract in all eyes but cases no 4,5 and 7 de-
veloped cataract after vitrectomy. There was no history
of trauma or macular hole in all 7 eyes.
In 3 patients there was a history of intravitreal injec-
tion of triamcinolone acetonide to treat attacks of panu-
veitis (2 eyes) or resistant cystoid macular edema (1 eye).
All cases were injected in other clinics. In all 3 eyes, the
detachment occurred within 8 weeks from the injection
time. In one patient (case No. 4), the primary tear was
masked by the concomitant posterior uveitis. In one pa-
tient (case No.7) there was combined tractional and
rhegmatogenous RD secondary to old branch retinal
vein occlusion (BRVO) with posterior small round tear
just inside the upper arcade. In patients (1,2,4,5 and 6)
single horseshoe tear was detected at or anterior to
equator. , while in case No.3 multiple pre-equatorial ret-
inal holes were found in two quadrants.
Five eyes were treated by conventional scleral buckling
and 2 eyes were treated by PPV. Initial surgical reattach-
ment was achieved in all seven eyes. In one eye (case
No.5), the detachment recurred after SB due to occur-
rence of PVR. This patient was re-operated by PPV with
successful reattachment.
The mean duration of follow up was 22.0 ± 6.7 months.
In patients 4, 5 and 7, the oil was removed 6 months
after vitrectomy. Cataract extraction via phacoemulsifi-
cation with intraocular lens implantation was performed
at the same time of oil removal, the retina remained at-
tached in all eyes after silicone oil removal.
All patients received systemic and topical steroids
prior to surgery. Mild to moderate anterior uveitis (+2
cells) and vitritis developed in cases no 2 and 6. Cystoid
macular edema recurred in cases no 2 and 3 with the
need to repeated triamcinolone injection 7 and 8 weeks
postoperative respectively.
All patients had preoperative best corrected visual acuity
of hand motion (HM) or finger counting (FC) and at the
last follow up visual acuity improved in 6 (85.7%) eyes and
did not change in one eye. Macular ischemia was observed
in eyes with poor postoperative VA (case No.7).
Discussion
Posterior segment involvement in BD often leads to irre-
versible and serious vision loss. Although most retinal
manifestations of the disease have been reported in the
literature, rhegmatogenous RD is rarely discussed in de-
tails. The current study presents a case series of patients
Table 1 Clinical characters of the eyes with rhegamtougenous retinal detachment associated with Behçet’s disease



















Pre operative Post operative
Snellen Logmar Snellen Logmar
1 32 Male Right 5 Total RD 3 days Vitritis ˗ FC +2.00 6/18 0.5 Segmental SB 30
2 42 Male Right 4
Temporal RD
with Macula-off
10 days Vitritis + HM +3.00 3/60 1.3 Segmental SB 27
3 39 Male Left 7
Lower RD with
macula-off
7 days BRVO + HM +3.00 3/60 1.3 Encircling SB 16
4 30 Male Left 3 Total RD 5 days
Panuveitis, PVR
Grade C
˗ FC +2.00 6/36 0.8 PPV 18





6 34 Male Left 7 Total RD 8 days BRVO ˗ FC +2.00 6/60 1.0 Segmental SB 29
7 35 Male Left 7 Combined TRD - RRD 14 days BRVO, NV, VH + FC +2.00 FC 2.0 PPV 21
RD = retinal detachment, VA = visual acuity, SB = scleral buckling, PPV = pars plana vitrectomy, PVR = proliferative vitreoretinopathy, IVTA = intravitreal triamcinolone acetonide, RD = retinal detachment, RRD =
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on the clinical course and visual outcome with surgical
intervention.
The study describe herein showed that 85.7% of the
patients were males with 85.7% of them less than
40 years of age. These findings are concordant with pre-
vious studies that have shown a male preponderance
and it is generally associated with a more severe form of
the disease in men, and a younger age of onset [1,3,4,6].
Previously, Akova et al. [14] reported the occurrence
of rhegmatogenous RD in 3 eyes during the active stage
of uveitis. Similarly in our cohort, one patient developed
the detachment during the active stage of posterior
uveitis and we confirm this possibility that uveitis may
lead to retinal tear formation. In the current study, three
patients (42.9%) had a history of IVTA within 8 weeks
prior to the occurrence or rhegmatogenous RD. There-
fore, we speculate IVTA may be a possible risk factor for
retinal detachment. One possibility is that IVTA may
induce posterior vitreous detachment with a risk to
develop retinal tear at areas of abnormal vitreoretinal at-
tachments. This agrees with Geck et al. [16] who re-
ported the occurrence of PVD in 15 out of 61 eyes after
intravitreal drug injection which may influence the out-
come of underlying disease. Alternatively, the posterior
uveitis itself may lead to vitreous gel shrinkage and de-
velopment of tractional forces especially at areas with
poor perfusion and the occurrence of rhegmatogenous
RD. Therefore, patients who receive IVTA should be
followed up cautiously after the injection for the risk of
rhegmatogenous RD.
Primary scleral buckling was successful in 4 out of 5
patients (80%) during the follow up period. Only in one
patient (case No. 5) scleral buckle failed due to PVR and
retina was successfully reattached by PPV and silicone
oil injection. In 2 patients (case No. 4 and No. 7) pri-
mary pars plana vitrectomy was done due to presence
of PVR grade C (case No. 4) and combined tractional
and rhegmatogenous RD (case No.7) with successful re-
attachment of the retina in both eyes. Therefore, Scleral
buckling yielded good anatomical results in cases with
simple retinal detachment especially in absence of PVR.
Although some retina specialties may argue the value of
buckling in these cases, it is still one successful option.
All patients received topical and systemic prednisolone
in the perioperative period and tapered over a long period
according to the clinical course, which we believe that it is
an essential part of the therapy to avoid any exacerbations
following surgery. The mean duration of postoperative
follow-up in this study was considerable (22.0 ± 6.7 months)
to address the surgical outcome, however larger studies are
needed to address the long term outcome especially in BD
where the recurrent exacerbations are expected to induce
further complications.The improvement in the VA was obtained in 6 out of
7 patients (85.7%), however the final visual outcome
was limited. The reasons for that are the poor visual
acuity at initial presentation, macular involvement in all
cases and noticeable macular ischemia in eyes with
poor visual outcome.
The current study had some limitations. First, the
number of eyes with rhegmatogenous RD was relatively
small. Second, there is limited information on the nat-
ural course of rhegmatogenous RD in such cases. Third,
although some factors are thought to predispose to rheg-
matogenous detachment, possibly panuveitis and IVTA,
other possible precipitating factors need to be identified.
Conclusion
In conclusion, even though rhegmatogenous RD is a rare
posterior segment complication of BD but it should
be kept in mind especially if the patient presented with
marked diminution of vision on top of the chronic course
of the disease and careful examination should be consid-
ered especially in cases with media opacity. Segmental
scleral buckle or Pars Plana Vitrectomy are effective and
save in management of this complication in BD patient
with no unusual complications. Intravitreal injection of
TA may be a precipitating factor for the development of
rhegmatogenous RD so close observation of such patients
after injection is crucial. Larger case series over longer fol-
low up periods are needed to understand the natural
course of the disease and accumulate more evidence on
the surgical outcome.
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